Drug-induced renal function impairment: A population-based survey

Pharmacoepidemiology and Drug Safety

Volumn 12, Issue 2, 2003, Pages 135-143

  Monster, Taco B M ^a   de Jong, Paul E ^a   de Jong van den Berg, Lolkje T W ^a   Navis, G J ^b   Verhave, J C ^b   Gans, R O B ^b   Smit, A J ^b   Stuveling, E ^b   van Veldhuisen, D J ^b   van Boven, A J ^b   Asselbergs, F ^b   van Gilst, W H ^b   de Zeeuw, D ^b   Hillege, H L ^b   Postma, M ^b   te Meerman, G J ^b   Broer, J ^b   Grobbee, D E ^c  

^a UNIVERSITY OF GRONINGEN   (Netherlands)

^b UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^c UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

Adverse effects; Drug therapy; Kidney failure; Pharmacoepidemiology

Indexed keywords

AMINOGLYCOSIDE DERIVATIVE; ANALGESIC AGENT; ANTACID AGENT; ANTICOAGULANT AGENT; ANTIDIABETIC AGENT; ANTIHYPERTENSIVE AGENT; ANTIINFECTIVE AGENT; ANTIRHEUMATIC AGENT; ANTIULCER AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CARDIAC AGENT; CIMETIDINE; CORTICOSTEROID; CREATININE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; EYE DROPS; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LAXATIVE; MACROLIDE; NONSTEROID ANTIINFLAMMATORY AGENT; PARACETAMOL; PENICILLIN DERIVATIVE; SEX HORMONE; SULFONAMIDE; TETRACYCLINE DERIVATIVE; TRIMETHOPRIM; UNINDEXED DRUG; VACCINE;

ADULT; AGE; AGED; ARTICLE; CHRONIC KIDNEY FAILURE; COHORT ANALYSIS; CONTROLLED STUDY; CREATININE CLEARANCE; DRUG INDUCED DISEASE; DRUG SURVEILLANCE PROGRAM; DRUG USE; FEMALE; GLOMERULUS FILTRATION; HUMAN; INTERSTITIAL NEPHRITIS; KIDNEY DYSFUNCTION; KIDNEY FUNCTION; KIDNEY FUNCTION TEST; KIDNEY TUBULE NECROSIS; MAJOR CLINICAL STUDY; MALE; POPULATION RESEARCH; PREVALENCE; PRIORITY JOURNAL; SEX; ULTRAFILTRATION;

ADULT; AGED; COHORT STUDIES; CREATININE; FEMALE; GLOMERULAR FILTRATION RATE; HUMANS; KIDNEY; KIDNEY DISEASES; MALE; MIDDLE AGED; PHARMACEUTICAL PREPARATIONS; QUESTIONNAIRES;

EID: 0344406225     PISSN: 10538569     EISSN: None     Source Type: Journal    
DOI: 10.1002/pds.811     Document Type: Article

References (28)

1. De Broe ME, Porter GA, Bennett WM, Verpooten GA. Clinical Nephrotoxins. Renal Injury From Drugs and Chemicals. Kluwer: Dordrecht, 1998.
2. Swanepoel CR, Cassidy MJD. Renal disorders. In Davies's Textbook of Adverse Drug Reactions (5th edn), Chapt 14, Davies DM, Ferner RE, De Glanville H (eds). Chapman & Hall Medical: London, 1998; 339-380.
3. Ravnskov U. Glomerular, tubular and interstitial nephritis associated with non-steroidal antiinflammatory drugs. Evidence of a common mechanism. Br J Clin Pharmacol 1999; 47(2): 203-210.
4. Farrugia E. Drug-induced renal toxicity: diagnosis and prevention. Hosp Med 1998; 59(2): 140-144.
5. Redon J. Renal protection by antihypertensive drugs: insights from microalbuminuria studies. J Hypertens 1998; 16(12 Pt 2): 2091-2100.
6. Orchard RT, Rooker G. Letter: penicillin-hypersensitivity nephritis. Lancet 1974; 1(7859): 689.
7. Sakarcan A, Marcille R, Stallworth J. Antibiotic-induced recurring interstitial nephritis. Pediatr Nephrol 2002; 17(1): 50-51.
8. Rossert J. Drug-induced acute interstitial nephritis. Kidney Int 2001; 60(2): 804-817.
9. Smith EJ, Light JA, Filo RS, Yum MN. Interstitial nephritis caused by trimethoprim-sulfamethoxazole in renal transplant recipients. JAMA 1980; 244(4): 360-361.
10. Richmond JM, Whitworth JA, Fairley KF, Kincaid-Smith P. Co-trimoxazole nephrotoxicity. Lancet 1979; 1(8114): 493.
11. Porile JL, Bakris GL, Garella S. Acute interstitial nephritis with glomerulopathy due to nonsteroidal anti-inflammatory agents: a review of its clinical spectrum and effects of steroid therapy. J Clin Pharmacol 1990; 30(5): 468-475.
12. Bennett WM, Luft F, Porter GA. Pathogenesis of renal failure due to aminoglycosides and contrast media used in roentgenography. Am J Med 1980; 69(5): 767-774.
13. Alkhuja S, Aboudan M, Menkel R. Acetaminophen toxicity induced non-oliguric acute tubular necrosis. Nephrol Dial Transplant 2001; 16(1): 190.
14. Bjørck S, Svalander CT, Aurell M. Acute renal failure after analgesic drugs including paracetamol (acetaminophen). Nephron 1988; 49(1): 45-53.
15. Barbour VM, Williams PF. Nephrotic syndrome associated with sulphasalazine. BMJ 1990; 301(6755): 818.
16. Mathew TH. Drug-induced renal disease. Med J Aust 1992; 156(10): 724-729.
17. Elseviers MM, De Broe ME. Combination analgesic involvement in the pathogenesis of analgesic nephropathy. The European perspective. Am J Kidney Dis 1996; 28(Suppl. 1): S48-S55.
18. Ritz E, Tarng DC. Renal disease in type 2 diabetes. Nephrol Dial Transplant 2001; 16(Suppl. 5): 11-18.
19. Ruggenenti P, Remuzzi G. Nephropathy of type 1 and type 2 diabetes: diverse pathophysiology, same treatment? Nephrol Dial Transplant 2000; 15(2): 1900-1902.
20. Basta E, Bakris GL. Evolution of drugs that preserve renal function. J Clin Pharmacol 2000; 40(9): 978-989.
21. Baigent C, Wheeler DC. Should we reduce blood cholesterol to prevent cardiovascular disease among patients with chronic renal failure? Nephrol Dial Transplant 2000; 15(8): 1118-1119.
22. Hostetter TH, Olson JL, Rennke HG, Venkatachalam MA, Brenner BM. Hyperfiltration in remnant nephrons: a potentially adverse response to renal ablation. Am J Physiol 1981; 241(1): F85-F93.
23. Mogensen CE, Hansen KW, Nielsen S, Pedersen MM, Rehling M, Schmitz A. Monitoring diabetic nephropathy: glomerular filtration rate and abnormal albuminuria in diabetic renal disease-reproducibility, progression, and efficacy of antihypertensive intervention. Am J Kidney Dis 1993; 22(1): 174-187.
24. Pinto-Sietsma S-J, Janssen WMT, Hillege HL, Navis G, De Zeeuw D, De Jong PE. Urinary albumin excretion is associated with renal functional abnormalities in a nondiabetic population. J Am Soc Nephrol 2000 11(10): 1882-1888.
25. Monster TBM, Janssen WMT, De Jong PE, De Jong-van den Berg LTW. Pharmacy data in epidemiological studies: an easy to obtain and reliable tool. Pharmacoepidemiol Drug Safe 2002; 11: 379-384.
26. WHO Collaborating Centre for Drug Statistics Methodology. ATC Index With DDDs 2001. WHO: Oslo, 2001.
27. Berg KJ, Gjellestad A, Nordby G, Rootwelt K, Djøseland O. Fauchald P, et al. Renal effects of trimethoprim in ciclosporin- and azathioprine-treated kidney-allografted patients. Nephron 1989; 53(3): 218-222.
28. Ribstein J, Halimi JM, Du Cailar G, Mimran A. Renal characteristics and effect of angiotensin suppression in oral contraceptive users. Hypertension 1999; 33(1): 90-95.